| Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 16442893 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cardiac tamponade is a life-threatening complication of acute myocardial infarction (MI). Data on the incidence, risk factors, and outcome of tamponade in patients with acute MI in the fibrinolytic era are limited. METHODS: Data from a combined clinical trials database of ST-segment elevation MI were used to evaluate the incidence of cardiac tamponade, baseline characteristics, and outcomes in patients with and without tamponade. Univariable and multivariable analyses assessed the relationship between patient characteristics and tamponade development, and the influence of tamponade on mortality. RESULTS: Of 102,060 patients, 865 (0.85%) developed isolated cardiac tamponade during initial hospitalization. Patients with tamponade were older (median 71.9 vs 61.6 years, P < .001), were more likely to be female (54.0% vs 25.1%, P < .001), were more likely to have an anterior MI (61.9% vs 41.5%, P < .001), and had a longer time from symptom onset to reperfusion (median 3.5 vs 2.8 hours, P < .001) than those without tamponade. Multivariable analyses identified increasing age, anterior MI location, female sex, and increased time from symptom onset to treatment as significant independent predictors of tamponade. Patients with tamponade had an increased death rate at 30 days (hazard ratio 7.9, 95% CI 4.7-13.5). CONCLUSION: Cardiac tamponade occurs in < 1% of patients with fibrinolytic-treated acute MI and is associated with increased 30-day mortality. Time from symptom onset to treatment strongly predicted the development of tamponade, underscoring the need for continued efforts to increase speed to treatment in acute MI. |
| | |
Authors:
|
Manesh R Patel; Trip J Meine; Lauren Lindblad; Jeffrey Griffin; Christopher B Granger; Richard C Becker; Frans Van de Werf; Harvey White; Robert M Califf; Robert A Harrington |
Related Documents
:
|
122753 - The postpericardiotomy syndrome then and now. 2133853 - The surgeon's response to a low-output state after cardiopulmonary bypass: etiologies a... 9201113 - Effect of chronic digoxin on beta-adrenergic receptors in rabbits with heart failure. |
Publication Detail:
|
Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American heart journal Volume: 151 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-30 Completed Date: 2006-02-10 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States |
Other Details:
|
Languages: eng Pagination: 316-22 Citation Subset: AIM; IM |
Affiliation:
|
Duke Clinical Research Institute, Durham, NC 27715, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Age Factors Aged Analysis of Variance Cardiac Tamponade / drug therapy, etiology*, mortality Coronary Angiography Databases, Factual Female Fibrinolytic Agents / therapeutic use* Humans Male Middle Aged Myocardial Infarction / complications*, mortality, pathology Proportional Hazards Models Randomized Controlled Trials as Topic Sex Factors Thrombolytic Therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: External validation of a percutaneous coronary intervention mortality prediction model in patients w...
Next Document: Evaluating the performance of the Global Registry of Acute Coronary Events risk-adjustment index acr...